Keywords: Bioacrtis, Johnson & Johnson, Debiopharm, Financing

J&J and Debiopharm get stakes in Biocartis, as part of 30 million-euro financing round

Article | 09 April 2010

Print This

Biocartis SA, a Swiss biotech company active in the field of personalized medicine and focused on fast, multiplexed and fully ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in